Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 25935 relapse prevention in alcohol dependence
2008-005318-35Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol dependence comparing Org 25935 with Placebo (2 arms). Primary endpoint: Percentage of heavy drinking days. Started Oct 2008; status: terminated.
02
Drugs
org 25935
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2008-005318-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005318-35.